Ribociclib (Kisqali) is already used to treat advanced hormone receptor-positive (HR-positive) breast cancer. Now new research has shown it can also reduce the risk of recurrence when used in early breast cancer.
BCAC is confident that Pharmac’s switch of breast cancer drug Herceptin (trastuzumab) to Herzuma, a biosimilar version, will be safe and effective, but we wonder why it took so long to fund this cheaper alternative. BCAC is also disappointed that access has not been extended to those who need retreatment in advanced breast cancer.
Jess Coate (Ngapuhi), fitness instructor and bodybuilding pro, organised a hugely successful fun fitness and learning event for BCAC, attended by 80 women in Kirikiriroa Hamilton recently. Jess teamed up with BCAC to raise awareness of the danger breast cancer poses to young women. Watch this awesome video of the event with some vital messages!
While drugs given during chemotherapy can help to combat nausea, more than half of patients also suffer from delayed nausea and vomiting. This kicks in after chemo has finished and can last for days. Some oncologists had reported that pantoprazole, a proton pump inhibitor which reduces stomach acid, was helpful for these patients. However, others were not convinced.
BCAC welcomed the opportunity to have input into the Ministry of Health’s new Women’s Health Strategy for Aotearoa New Zealand (read our submission here). BCAC stressed the importance of including breast cancer in this strategy and identified three key issues:
BCAC is alarmed by Pharmac’s proposal to review a rule that currently allows children with cancer to have free access to unfunded medicines. Read BCAC’s submission here.
BCAC has grave concerns about the potential impacts of the Therapeutic Products Bill as currently drafted and has written a submission to the Health Select Committee on this.
BCAC is aware that the breast cancer experience presents some unique challenges for LGBTQI+ people. We were pleased to see that the Cancer Council of New South Wales has produced a new online resource to help.
BCAC has responded to a call from Te Manatū Hauora (Ministry of Health) for input on the topic of Precision Health, which is being considered for inclusion in the next Long-term Insights Briefing to Government. BCAC’s Fay Sowerby has written a comprehensive…
BCAC welcomes the Breast Cancer Foundation’s new survey to learn more about the long-term side effects of treatments for early breast cancer. ‘It’s good to see more research on the experiences of NZ women with breast cancer’ says BCAC Chair Libby Burgess. ‘We encourage you to participate in this research if you can.’ Update 1 May 2023: the survey has now closed. You can learn more about the results by contacting the Breast Cancer Foundation at intouch@bcf.org.nz Read more about the survey…
